-
1
Glucose-Lowering Agents Developed in the Last Two Decades and Their Perioperative Implications
Published 2024-12-01Subjects: Get full text
Article -
2
Effect of Imeglimin, a Novel Anti-Diabetic Agent, on Insulin Secretion and Glycemic Variability in Type 2 Diabetes Treated with DPP-4 Inhibitor: A 16-Week, Open Label, Pilot Study
Published 2025-01-01Subjects: “…imeglimin…”
Get full text
Article